Pemetrexed (Alimta);Pemetrexed Alimta

Internistische Praxis

Volumn 47, Issue 2, 2007, Pages 377-383

  Serke, Monika ^a   Loddenkemper, R ^a  

^a HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYANOCOBALAMIN; DOCETAXEL; PEMETREXED;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ARTICLE; BREAST CANCER; CHEMOTHERAPY; CLINICAL TRIAL; COLORECTAL CARCINOMA; COMBINATION CHEMOTHERAPY; DIARRHEA; DRUG BINDING; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; FATIGUE; HUMAN; LUNG TOXICITY; MESOTHELIOMA; MONOTHERAPY; NAUSEA; NEUROTOXICITY; PANCREAS CARCINOMA; SIDE EFFECT; STOMATITIS; TREATMENT INDICATION;

EID: 34248136354     PISSN: 00209570     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Shih C, et al. LY231514, a pyrrolo (2,3-d)pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes. Cancer Res 1997; 57: 1116-1123.
2. Hanauske AR, Peters HD. Multi-targeted-Enzyminhibition in der Tumortherapie. Entwicklung von Pemetrexed. Onkologe 2005; 12: 1321-1337.
3. Rinaldi DA, et al. A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation. Cancer Chemother Pharmacol 1999; 44: 372-380.
4. Serke M, Loddenkemper R. Therapeutische Optionen beim malignen Pleuramesotheliom. Pneumologie 2005; 59: 1-12.
5. Scagliotti GV, et al. Phase II study of pemetrexed with and without folic acid and vitamin B12 as frontline therapy in malignant pleural mesothelioma. J Clin Oncol 2003; 8: 1556-1561.
6. Vogelzang NJ, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone inpatients with malignant pleural mesothelioma. J Clin Oncol 2003; 21: 2636-2644.
7. Shepherd FA, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 2000; 18: 2095-2103.
8. Pfister DG, et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004: 22: 330-353.
9. Hanna N, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004; 22: 1589-1597.
10. Oettle H, et al. A phase III trial of Pemetrexed plus Gemcitabine versus Gemcitabine in patients with unresectable or metastatic pancreatic cancer. Ann Oncol 2005; 16: 1639-1645.